Federal Register: HHS Weighs Exclusive Patent Licensing Deal With MedGene Therapeutics
September 17, 2026
September 17, 2026
WASHINGTON, Sept. 17 (TNSFR) -- The U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute issued the following action in the Federal Register:
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents and patent applications listed in the Supplementary Information s . . .
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents and patent applications listed in the Supplementary Information s . . .